We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Aratana Therapeutics, Inc. | NASDAQ:PETX | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 4.92 | 4.40 | 7.16 | 0 | 01:00:00 |
From May 2019 to May 2024
LEAWOOD, Kan., May 16, 2017 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative therapeutics for dogs and cats, plans to present at three upcoming investor conferences, including:
2017 Stifel Dental and Veterinary Conference in New York City
Wednesday, May 31 at 3:35 p.m. ET
Listen to the Stifel webcast
Jefferies 2017 Global Healthcare Conference in New York City
Wednesday, June 7, 2017 at 3:00 p.m. ET
Listen to the Jefferies webcast
William Blair 2017 Growth Stock Conference in Chicago
Wednesday, June 14, 2017 at 9:40 a.m. ET
Listen to the William Blair webcast
Interested parties may listen live or access the audio link for up to 90 days after the meeting. Presentation slides from the conference will also be available in the Aratana Investor Room.
About Aratana Therapeutics
Aratana Therapeutics is a pet therapeutics company focused on licensing, developing and commercializing innovative therapeutics for dogs and cats. Aratana believes that it can leverage the investment in the human biopharmaceutical industry to bring therapeutics to dogs and cats in a capital and time efficient manner. The company's pipeline includes therapeutic candidates for the potential treatment of pain, inappetence, viral diseases, allergy, cancer and other serious medical conditions. Aratana believes the development and commercialization of these therapeutics will permit veterinarians and pet owners to manage pets' medical needs safely and effectively, resulting in longer and improved quality of life for pets. For more information, please visit www.aratana.com.
Contacts
For investor inquires:
Craig Tooman
ctooman@aratana.com
(913) 353-1026
For media inquiries:
Rachel Reiff
rreiff@aratana.com
(913) 353-1050
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/aratana-therapeutics-to-participate-at-three-upcoming-investment-conferences-300457700.html
SOURCE Aratana Therapeutics, Inc.
Copyright 2017 PR Newswire
1 Year ARATANA THERAPEUTICS, INC. Chart |
1 Month ARATANA THERAPEUTICS, INC. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
